Literature DB >> 27090770

Short-Term Outcomes of Patent Ductus Arteriosus Closure With New Occlutech® Duct Occluder: A Multicenter Study.

Reyhan Dedeoglu1, Meki Bilici2, Fikri Demir2, Fadli Demir3, Onur Çağlar Acar4, Olgu Hallioglu5, Ayşenur Pac6, Alev Kiziltas7, Duran Karabel8, Serdar Kula9, Derya Cimen10, Osman Baspinar11, Sezen Ugan Atik1, Irfan Levent Saltik1.   

Abstract

AIM: Over the past 2 decades, transcatheter occlusion of patent ductus arteriosus (PDA) with coils and the duct occluders evolved to be the procedure of choice. A new device, the Occlutech PDA® occluder (ODO) device has been designed. Herein, we aimed to evaluate the characteristics and short-term results of patients who underwent transcatheter closure of PDA using the ODO.
METHODS: We reviewed the clinical records of 60 patients from different centers in Turkey between December 2013 and January 2016. The medical records were reviewed for demographic characteristics and echocardiographic findings. Device size was selected on the narrowest diameter of PDA.
RESULTS: The median patient age was 2.5 years (6 months-35 years), and median PDA diameter was 2.5 mm (1.2-11 mm). Fifty-eight of 60 patients (96.6%) had successful ODO implantation. The occlusion rates were 37/58 (63.7%) at the end of the procedure, 51/58 (87.9%) at 24-48 hours post-procedure, and 57/58 (98.2%) on echocardiography at a median follow-up of 7.6 months.
CONCLUSION: Our results indicate that transcatheter closure of PDA using the ODO is effective. Larger studies and longer follow-up are required to assess whether its shape and longer length make it superior to other duct occluders in large, tubular, or window-type ducts. (J Interven Cardiol 2016;29:325-331).
© 2016, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27090770     DOI: 10.1111/joic.12290

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  4 in total

1.  Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder.

Authors:  Meki Bilici; Fikri Demir; Alper Akın; Mehmet Türe; Hasan Balık; Mahir Kuyumcu
Journal:  Pediatr Cardiol       Date:  2017-08-21       Impact factor: 1.655

2.  Clinical study of stand-alone transthoracic echocardiography-guided percutaneous occlusion of patent ductus arteriosus.

Authors:  Hua Cao; Qiang Chen; Gui Can Zhang; Liang Wan Chen; Fan Xu; Jia-Xin Zhang
Journal:  Anatol J Cardiol       Date:  2018-07       Impact factor: 1.596

3.  Percutaneous closure of patent ductus arteriosus with the Nit-Occlud® patent ductus arteriosus device in 268 consecutive cases.

Authors:  Andrii V Maksymenko; Yulia L Kuzmenko; Arkadii A Dovhaliuk; Oleksandra O Motrechko; Florian E Herrmann; Nikolaus A Haas; Anja Lehner
Journal:  Ann Pediatr Cardiol       Date:  2019 Sep-Dec

4.  Patent ductus arteriosus closure using Occlutech® Duct Occluder, experience in Port Elizabeth, South Africa.

Authors:  Lungile Pepeta; Adele Greyling; Mahlubandile Fintan Nxele; Zongezile Masonwabe Makrexeni
Journal:  Ann Pediatr Cardiol       Date:  2017 May-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.